Glycotest Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.22M

  • Investors
  • 5

Glycotest General Information

Description

Developer of a liver disease diagnostics technology intended to commercialize new and unique blood tests for life-threatening cancers and fibrosis-cirrhosis. The company's platform provides non-invasive blood tests based on proprietary serum biomarkers, biomarker panels, and assay technology that exploit novel sugar-based disease signal chemistry, enabling patients with serious diseases to access novel clinical laboratory testing services and experience early detection of liver cancer and chronic disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 613 Schiller Avenue
  • Suite 817
  • Merion, PA 19066
  • United States
+1 (484)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Drug Discovery
Vertical(s)
Corporate Office
  • 613 Schiller Avenue
  • Suite 817
  • Merion, PA 19066
  • United States
+1 (484)

Glycotest Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycotest Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 16-Jul-2026 $3.22M Completed Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC (Series A) 23-Jan-2024 Completed Generating Revenue
5. Accelerator/Incubator 01-Jun-2019 Completed Clinical Trials - Phase 3
4. Later Stage VC (Series A) 05-Feb-2019 Completed Clinical Trials - Phase 3
3. Buyout/LBO 31-Dec-2016 Completed Clinical Trials - General
2. Accelerator/Incubator 05-Jun-2012 $500K $500K Completed Stealth
1. University Spin-Out 01-Jan-2012 Completed Stealth
To view Glycotest’s complete valuation and funding history, request access »

Glycotest Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-4 5,846,587 $0.001000 8% $0.38 $0.38 1x $0.38 3.48%
Series A-1 40,785,357 $0.001000 8% $0.51 $0.51 1x $0.51 24.29%
To view Glycotest’s complete cap table history, request access »

Glycotest Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a liver disease diagnostics technology intended to commercialize new and unique blood tests for life-threat
Biotechnology
Merion, PA
2 As of 2026

Enid, OK
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Glycotest Competitors (1)

One of Glycotest’s competitors is Wako., a Corporation company based in Enid, OK.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wako. Corporation Enid, OK
You’re viewing 1 of 1 competitors. Get the full list »

Glycotest Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glycotest Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator Minority
Baruch S. Blumberg Institute Corporation Minority
Fosun Pharma Corporation Majority
EMV Capital Venture Capital Minority
Drexel University University Minority
To view Glycotest’s complete investors history, request access »

Glycotest FAQs

  • When was Glycotest founded?

    Glycotest was founded in 2012.

  • Where is Glycotest headquartered?

    Glycotest is headquartered in Merion, PA.

  • What is the size of Glycotest?

    Glycotest has 2 total employees.

  • What industry is Glycotest in?

    Glycotest’s primary industry is Biotechnology.

  • Is Glycotest a private or public company?

    Glycotest is a Private company.

  • What is the current valuation of Glycotest?

    The current valuation of Glycotest is .

  • What is Glycotest’s current revenue?

    The current revenue for Glycotest is .

  • How much funding has Glycotest raised over time?

    Glycotest has raised $16.2M.

  • Who are Glycotest’s investors?

    MedTech Innovator, Baruch S. Blumberg Institute, Fosun Pharma, EMV Capital, and Drexel University have invested in Glycotest.

  • Who are Glycotest’s competitors?

    Wako. is a competitor of Glycotest.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process